Guidelines for laser treatment in diabetic retinopathy aimed at preserving the driving field are presented.
For the last 15-20 years, panretinal photocoagulation (PRP) has been the mainstay of treatment for diabetics with proliferative retinopathy. Many reports have shown its value in inducing neovascular regression and preserv ing visual acuity. 1.2 Although Xenon arc was used in the early years, lasers are now preferred by most ophthalmologists. A standard treatment consists of up to 2000 argon bums at the 500 micron setting scattered over the peripheral retina with further photocoagulation where necessary:l For the last five years it has been policy in our diabetic retinal clinic to use 200 micron bums for PRP in the initial treatment pro tocol as this size of bum is often easier for the patient to tolerate and for the operator to deliver.
Many patients receiving PRP to both eyes continue to drive maintaining a binocular acuity acceptable to the DVLC. This valuable asset is often necessary for their continued employment.
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Diabetics should inform the DVLC following laser treatment to both eyes. They are then obliged to undertake a formal acuity and field test.
Reading a number plate at 25 yards equates to a bin ocular acuity of approximately 6/10. 4 The British field regulations require the patient to have a binocular field to a 4 mm target that spans 1200 horizontally by 400 ver tically.s A person with normal vision will pass this on one eye alone.
Previous studies have confirmed that photocoagulation with bums of 500 micron diameter is associated with loss of peripheral visual field.6.7 Generalised constriction and isolated scotomas may occur, particularly if confluent bums are used to close new vessels directly. Loss of visual field in both eyes may prejudice the ability of an individual to pass the United Kingdom DVLC field regulations.
In order to define risk factors for failing the DVLC field regulations, we reviewed the notes of all patients who had bilateral PRP between July 1986 and June 1990.
PATIENTS AND METHOD
Patients with a binocular acuity of 6/9 or better had Gold mann fields performed. The field technician was unaware of the treatment the subject had received. Each eye was tested separately using kinetic and static targets. Static tests were performed at each intersection on the Gold mann chart within the 1200 by 400 parameters determined by the DVLC.
A 'clear pass' was recorded if there were no points missed within the 1200 by 400 zone which would result in a binocular scotoma. For example, a missed point in the field of one eye could be compensated by a point seen in the corresponding position in the field of the other eye.
It is recognised that the Visual Standards Committee advising the DVLC uses more detailed criteria to judge borderline cases. Therefore patients whose fields demon strated constriction within the 1200 by 400 parameters or whose fields contained binocular scotomas had their fields assessed by the Chairman of the Visual Standards Com- mittee of the College of Ophthalmologists (CVSC). This assessment was performed without knowledge of the details of laser treatment performed.
RESULTS
In the four-year period, 31 patients with bilateral PRP were considered to have had stable retinopathy for a mini mum of six months. Five were unavailable for analysis. Four had bilateral ischaemic maculopathy and failed on acuity, and one was demented. The remaining 21 patients had fields performed to DVLC standards.
Two patients treated with bilateral Xenon photocoag ulation had severe field constriction and were clear fail ures. Of the 19 patients treated with the laser, 10 were clear passes ( Table J) . The average number of bums per eye in this group was 3475. In total seven eyes from seven patients had clear passes on one eye alone. In 6/ 10 cases no bums greater than 200 microns had been delivered to either eye and the panfunduscope or indirect laser had not been used. The remaining nine patients treated with laser had their fields assessed by the CVSC. Details of their treatment are shown in Table II . Reasons for referral to the CVSC are shown in Table III . He considered that he would recom mend a limited term licence in six cases, one would be a definite fail (case I) and another case (case E) would require further consideration but would probably pass. Some important points may be illustrated by examination of some of these cases:
Patient C had one paracentral congruent static miss corresponding to an area of confluent bums above the fovea in both eyes (Figs. I and 2 ).
Patient D again had only one congruent static miss but had multiple misses in the nasal field of each eye fol lowing 500 micron bums to the temporal retinae (Fig. I) .
Patient I had 2500 bums at the 400 micron setting delivered to each eye with the panfunduscope lens. This lens increases the bum diameter to 650 micronsx and per ipheral constriction was marked in both eyes (Fig. 3) .
Patient J had direct treatment to new vessels on the disc of the right eye which had continued to bleed following PRP. The left eye received PRP with 3500 bums, 30% of these at the 500 micron setting (Fig. 3) .
Some additional important points can be illustrated by examination of some of those to record a clear pass:
Patient L was fortunate not to have any congruent misses (Fig. 4) following PRP with 500 micron bums in the right eye and indirect laser in the left eye.
Despite the left eye having had 150 bums at the 500 micron setting, with typical scotoma production, patient M passed on just his right eye which had 3238 bums, none larger than 300 microns, for disc and peripheral new vessels (Fig. 4) .
The 500 micron bums delivered to patient R were restricted to superior and inferior peripheral retina thus sparing the driving field (Fig. 5) .
We demonstrated a significant assocIatIOn between total bum area and field loss (p = 0.027 by Spearman's Rank Correlation Coefficient); a scattergram of bum area versus field loss within the DVLC field area is shown in Fig. 6 .
DISCUSSION
A recent report has indicated that, despite passing the number plate test, 80% of patients who have had bilateral PRP (presumably with 500 micron bums) for proliferative diabetic retinopathy will fail the current DVLC field test. 9 Our study, in which the predominant laser spot size used was 300 microns or less, indicates that successful photo coagulation in certain patients carries a high chance of being permitted to retain a private driving licence.
A number of our cases demonstrated static misses on field testing in association with the use of large laser spot sizes. The 4 mm target on the Goldmann perimeter sub tends an angle of 0.70 at the nodal point of the eye. This produces a 210 micron diameter spot on the retina of an eye of average axial length (Appendix I). A 500 micron laser bum will eclipse the DVLC target, which is approxi mately the same size as a 200 micron bum.
Laser spot area is proportional to the square of the radius. Therefore it is difficult to separate the effect of large spot size from the effect of increasing total bum area statistically. Our subject group was far too small to detect such a statistical association while controlling for the very powerful relationship between bum size and total bum area. Based on the results of our study, we estimate the required sample size to be approximately 600 patients.
An as yet unquantifiable factor affecting bum size is the expansion of laser bums after application.
III This probably relates to bum uptake (dependent on wavelength, power applied and absorption variation in individual eyes), and 459 bum circumference rather than bum area, since it is from the bum margin that such expansion occurs. Field loss induced by treating diabetic retinopathy with photocoagulation may be due to a number of mechan isms.11 Laser bums produce scotomas due to outer seg ment destruction, and nerve fibre bundle defects occur from thermal damage to the overlying nerve fibre layer (this is particularly likely if larger intraretinal vessels are hit by the laser beam). Secondary damage due to disorgan isation occurs following thermal damage to smaller vessels and laser adjacent to the disc may cause thermal damage to the optic nerve. For a given laser power, all the above mechanisms are more likely if larger retinal bum sizes are used. In addition it should be remembered that the ischaemic process per se can produce scotomas, from either retinal or optic nerve hypoperfusion.
As screening for retinopathy becomes more common, patients with pre-proliferative retinopathy or early new vessel formation will be referred in larger numbers for management by ophthalmologists. The fear of inducing field loss by panphotocoagulation may deter some sur geons from treatment when loss of acuity in the short term seems remote.
The recent Early Treatment Diabetic Retinopathy Study report has confirmed that scatter PRP with 500 micron bums significantly reduces the risk of developing severe visual loss, even in eyes without disc new vessels but warns that field loss is common. 12 None of the patients in our study with peripheral new vessels who were treated with small bum therapy in the absence of disc vessels had to be referred to the CVSc. This indicates that patients undergoing early treatment with smaller bums have a very low risk of losing their right to drive.
We have demonstrated that adequate PRP with 200 micron bums induces neovascular regression in many patients and is compatible with passing the DVLC field regulations. The use of larger bums of 500 micron size and above appears to reduce the chance of passing by increas ing total bum area. and also by increasing the probability of static test scotomata from each bum.
As a result of our study we present the following guide lines for panphotocoagulation of proliferative and severe preproliferative diabetic retinopathy in patients requiring a United Kingdom driving licence:
(I) Use small bums, preferably no larger than 200 micron real size, avoiding major vessels and retina within the temporal arcades. Between 3000 and 3500 carefully applied bums induces regression in all but severe cases.
(2) Beware of confluent treatment particularly in maculopathy.
(3) Remember that the panfunduscope and similar lenses magnify the laser bum size.
(4) The use of the indirect laser or the Xenon coag ulator should be reserved for recalcitrant cases as exten sive peripheral constriction and/or scotomas are common.
(5) Preservation of central vision is, however, the para mount aim, and sufficient treatment should be applied to Appendix. The DVLC target corresponds to a 2 \0 micron diameter image on the retina of an eye of average axial length.
induce neovascular regression. If additional photocoag ulation is required apply it initially to the superior and inferior retina so that it falls at least 20° from the midline horizontal, thus sparing the visual field considered most valuable for driving.
